Alliance Pharma plc

AIM:APH Stok Raporu

Piyasa değeri: UK£241.9m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Alliance Pharma Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Alliance Pharma is forecast to grow earnings and revenue by 72.3% and 5.5% per annum respectively. EPS is expected to grow by 85.9% per annum. Return on equity is forecast to be 10.6% in 3 years.

Anahtar bilgiler

72.3%

Kazanç büyüme oranı

85.9%

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi16.3%
Gelir büyüme oranı5.5%
Gelecekteki özkaynak getirisi10.6%
Analist kapsamı

Good

Son güncelleme30 Sep 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Investors Aren't Entirely Convinced By Alliance Pharma plc's (LON:APH) Revenues

Sep 10
Investors Aren't Entirely Convinced By Alliance Pharma plc's (LON:APH) Revenues

Is Alliance Pharma (LON:APH) A Risky Investment?

Jun 21
Is Alliance Pharma (LON:APH) A Risky Investment?

Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet

Feb 23
Not Many Are Piling Into Alliance Pharma plc (LON:APH) Just Yet

Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)

Nov 21
Estimating The Intrinsic Value Of Alliance Pharma plc (LON:APH)

We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt

May 26
We Think Alliance Pharma (LON:APH) Is Taking Some Risk With Its Debt

Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models

Mar 24
Alliance Pharma plc Just Missed Earnings - But Analysts Have Updated Their Models

We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt

Sep 30
We Think Alliance Pharma (LON:APH) Can Stay On Top Of Its Debt

An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued

May 28
An Intrinsic Calculation For Alliance Pharma plc (LON:APH) Suggests It's 41% Undervalued

Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet

Mar 30
Alliance Pharma (LON:APH) Has A Pretty Healthy Balance Sheet

Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?

Dec 24
Did Alliance Pharma's (LON:APH) Share Price Deserve to Gain 81%?

Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?

Nov 19
Do Fundamentals Have Any Role To Play In Driving Alliance Pharma plc's (LON:APH) Stock Up Recently?

Kazanç ve Gelir Büyüme Tahminleri

AIM:APH - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (GBP Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20262132432436
12/31/20252022030427
12/31/20241901626377
6/30/2024183-342930N/A
3/31/2024182-333031N/A
12/31/2023181-333131N/A
9/30/2023175-313030N/A
6/30/2023170-292929N/A
3/31/2023169-252525N/A
12/31/2022167-212021N/A
9/30/2022165-52627N/A
6/30/2022163123234N/A
3/31/2022163103336N/A
12/31/202116373439N/A
9/30/2021155133439N/A
6/30/2021147183439N/A
3/31/2021138133640N/A
12/31/202013083842N/A
9/30/2020131103337N/A
6/30/2020131112932N/A
3/31/2020133183034N/A
12/31/2019136253236N/A
9/30/2019133232832N/A
6/30/2019130212427N/A
3/31/2019124202125N/A
12/31/2018118181922N/A
9/30/2018112212224N/A
6/30/2018107242426N/A
3/31/201810427N/A27N/A
12/31/201710229N/A27N/A
9/30/201710125N/A27N/A
6/30/201710022N/A26N/A
3/31/20179920N/A22N/A
12/31/20169718N/A17N/A
9/30/20168518N/A13N/A
6/30/20167218N/A9N/A
3/31/20166015N/A9N/A
12/31/20154813N/A8N/A
9/30/20154711N/A9N/A
6/30/2015458N/A9N/A
3/31/2015448N/A10N/A
12/31/2014448N/A11N/A
9/30/2014448N/A11N/A
6/30/2014449N/A10N/A
3/31/2014459N/A10N/A
12/31/20134510N/A9N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: APH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).

Kazançlar ve Piyasa: APH is forecast to become profitable over the next 3 years, which is considered above average market growth.

Yüksek Büyüme Kazançları: APH is expected to become profitable in the next 3 years.

Gelir ve Pazar: APH's revenue (5.5% per year) is forecast to grow faster than the UK market (3.8% per year).

Yüksek Büyüme Geliri: APH's revenue (5.5% per year) is forecast to grow slower than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: APH's Return on Equity is forecast to be low in 3 years time (10.6%).

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y